The online version of this article (doi:10.1186/1477-7819-10-106) contains supplementary material, which is available to authorized users.
Authors had no financial competing interests on this article.
TN and MM carried out data collection and analysis, pathological examination, statistical part, and discussion part. KCK, TS and YM carried out pathological diagnosis as pathologist. YA, NK and SH carried out surgery. All authors read and approved the final manuscript.
Lymph node metastasis is one of the most important prognostic factors for extra-hepatic bile duct carcinoma (ExHBDC). Extra capsular lymph node involvement (ExCLNI) is the extension of cancer cells through the nodal capsule into the perinodal fatty tissue. The prognostic impact of ExCLNI has been shown to be significant mainly in head and neck malignancies. Recently, the prognostic impacts of ExCLNI have evaluated in gastrointestinal malignancies. However no data is available regarding the incidence and prognostic significance of extra-capsular lymph node involvement (ExCLNI) in resectable ExHBDCs. The aim of the present study is first to evaluate the incidence of ExCLNI in surgically-treated ExHBDCs and second, to determine the prognostic impact of ExCLNI in patients with surgically-treated ExHBDCs.
A total of 228 patients (110 cases of hilar cholangiocarcinoma and 118 cases of distal cholangiocarcinoma) with surgically-treated ExHBDCs were included in this retrospective study. ExCLNI was defined as the extension of cancer cells through the nodal capsule into the perinodal fatty tissue. The existence of ExCLNI and its prognostic value were analyzed as a subgroup of lymph node metastasis.
ExCLNI was detected in only 22% of patients with lymph node metastasis of surgically-treated ExHBDC. The presence of ExCLNI correlated with distal cholangiocarcinoma (p = 0.002). On univariate analysis for survival, perineural invasion, vascular invasion, histological grade, and lymph node metastasis were statistically significant factors. On multivariate analysis, only lymph node metastasis was identified as a significant independent prognostic factor in patients with resectable ExHBDC. Subgroups of lymph node metastasis including the presence of ExCLNI, location of lymph node metastasis, and the number of lymph node metastasis had no statistically significant impact on survival.
ExCLNI was present in only 22% of the LNM (7% of overall patients) in patients with surgical treated ExHBDCs. And ExCLNI would have no impact on the survival of patients with surgically-treated ExHBDCs.
Kondo S, Hirano S, Ambo Y, Tanaka E, Okushiba S, Morikawa T, Katoh H: Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg. 2004, 240: 95-101. 10.1097/01.sla.0000129491.43855.6b. PubMedCentralCrossRefPubMed
Nimura Y, Kamiya J, Kondo S, Nagino M, Uesaka K, Oda K, Sano T, Yamamoto H, Hayakawa N: Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepato-Biliary-Pan. 2000, 7: 155-162. 10.1007/s005340050170. CrossRef
Miyakawa S, Ishihara S, Horiguchi A, Takada T, Miyazaki M, Nagakawa T: Biliary tract cancer treatment: 5,584 results from the Biliary Tract Cancer Statistics Registry from 1998 to 2004 in Japan. J Hepato-Biliary-Pan. 2009, 16: 1-7. 10.1007/s00534-008-0015-0. CrossRef
Miyazaki M, Kimura F, Shimizu H, Yoshidome H, Otuka M, Kato A, Yoshitomi H, Furukawa K, Takeuchi D, Takayashiki T: One hundred seven consecutive surgical resections for hilar cholangiocarcinoma of Bismuth types II, III, IV between 2001 and 2008. J Hepatobiliary Pancreat Surg. 2009
Kawai M, Tani M, Kobayashi Y, Tsuji T, Tabuse K, Horiuchi T, Oka M, Yamaguchi K, Sakata Y, Shimomura T, Yamaue H: The ratio between metastatic and examined lymph nodes is an independent prognostic factor for patients with resectable middle and distal bile duct carcinoma. Am J Surg. 2010, 199: 447-452. 10.1016/j.amjsurg.2009.01.019. CrossRefPubMed
Surgery JSoB: The general rules for surgical and pathological studies on cancer of the biliary tract, 2nd edition. 2004, Tokyo: Kanehara, 2
Hirano S, Kondo S, Tanaka E, Shichinohe T, Tsuchikawa T, Kato K, Matsumoto J, Kawasaki R: Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality. J Hepato-Biliary-Pan. 2009, 17: 455-462. CrossRef
Nakanishi Y, Kondo S, Zen Y, Yonemori A, Kubota K, Kawakami H, Tanaka E, Hirano S, Itoh T, Nakanuma Y: Impact of residual in situ carcinoma on postoperative survival in 125 patients with extrahepatic bile duct carcinoma. J Hepatobiliary Pancreat Sci. 2010, 17: 166-173. 10.1007/s00534-009-0127-1. CrossRefPubMed
Imre K, Pinar E, Oncel S, Calli C, Tatar B: Predictors of extracapsular spread in lymph node metastasis. Eur Arch Oto-Rhino-L. 2008, 265: 337-339. 10.1007/s00405-007-0464-0. CrossRef
Di Giorgio A, Botti C, Sammartino P, Mingazzini P, Flammia M, Stipa V: Extracapsular lymphnode metastases in the staging and prognosis of gastric cancer. Int Surg. 1991, 76: 218-221. PubMed
- Evaluation of extra capsular lymph node involvement in patients with extra-hepatic bile duct cancer
Kanako C Kubota
- BioMed Central
Neu im Fachgebiet Chirurgie
Mail Icon II